What are the recommended antimicrobial treatments for common skin, Sexually Transmitted and Blood-Borne Infections (STBBI), and urinary infections in an adult patient with no significant underlying medical conditions, according to Canadian guidelines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Common Skin, STBBI, and Urinary Infections: Antimicrobial Treatment Guide

Skin and Soft Tissue Infections

Uncomplicated Cellulitis (Non-purulent)

Beta-lactam monotherapy is the standard of care, successful in 96% of patients, as MRSA is uncommon in typical cellulitis even in high-prevalence settings 1.

Oral regimens (first-line):

  • Cephalexin 500 mg every 6 hours for 5 days 1
  • Dicloxacillin 250-500 mg every 6 hours for 5 days 1
  • Amoxicillin 500 mg three times daily for 5 days 1
  • Penicillin V 250-500 mg four times daily for 5 days 1

IV regimens (hospitalized patients):

  • Cefazolin 1-2 g IV every 8 hours 1
  • Oxacillin 2 g IV every 6 hours 1

Treatment duration: Exactly 5 days if clinical improvement occurs; extend only if symptoms have not improved 1.

Purulent Cellulitis or MRSA Risk Factors

Add MRSA coverage when specific risk factors are present: penetrating trauma, injection drug use, purulent drainage/exudate, known MRSA colonization, or systemic inflammatory response syndrome 1.

Oral regimens:

  • Clindamycin 300-450 mg every 6 hours for 5 days (if local MRSA resistance <10%) 2, 1
  • Trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 double-strength tablets twice daily PLUS a beta-lactam (cephalexin or amoxicillin) for 5 days 2, 1
  • Doxycycline 100 mg twice daily PLUS a beta-lactam for 5 days 2, 1, 3

IV regimens:

  • Vancomycin 15-20 mg/kg IV every 8-12 hours (A-I evidence) 2, 1
  • Linezolid 600 mg IV twice daily (A-I evidence) 2, 1
  • Daptomycin 4 mg/kg IV once daily (A-I evidence) 2, 1

Critical caveat: Never use doxycycline or TMP-SMX as monotherapy for cellulitis—streptococcal coverage is inadequate 1.

Severe Cellulitis with Systemic Toxicity or Suspected Necrotizing Fasciitis

Mandatory broad-spectrum combination therapy is required for patients with fever, hypotension, tachycardia, altered mental status, or suspected necrotizing infection 1.

Recommended regimens:

  • Vancomycin 15-20 mg/kg IV every 8-12 hours PLUS piperacillin-tazobactam 3.375-4.5 g IV every 6 hours 1
  • Linezolid 600 mg IV twice daily PLUS piperacillin-tazobactam 1
  • Vancomycin PLUS a carbapenem (meropenem 1 g IV every 8 hours) 1

Duration: 7-14 days based on clinical response 1.

Skin Abscesses

Incision and drainage is the primary treatment; antibiotics play only a subsidiary role 1.

Antibiotics indicated only if:

  • Surrounding cellulitis present 2
  • Systemic signs of infection 2
  • Immunocompromised host 2
  • Multiple lesions 2

If antibiotics needed, use MRSA-active agents as above 2.

Bite Wounds (Animal and Human)

Amoxicillin-clavulanate 875/125 mg twice daily for 5-7 days provides single-agent coverage for polymicrobial oral flora 2, 1.

Alternative for penicillin allergy:

  • Doxycycline 100 mg twice daily PLUS metronidazole 500 mg three times daily 2
  • Moxifloxacin 400 mg daily (covers both aerobes and anaerobes) 2

Sexually Transmitted and Blood-Borne Infections (STBBI)

Gonorrhea (Urethritis/Cervicitis)

Ceftriaxone 250 mg IM as a single dose is first-line therapy 2.

Alternative (if ceftriaxone unavailable):

  • Azithromycin 2 g orally as a single dose 4

Note: Fluoroquinolones are no longer recommended due to widespread resistance 2.

Chlamydia (Urethritis/Cervicitis)

Azithromycin 1 g orally as a single dose 2, 4.

Alternative:

  • Doxycycline 100 mg orally twice daily for 7 days 2, 3

Non-Gonococcal Urethritis (NGU)

Doxycycline 100 mg orally twice daily for 7 days 2, 3.

Alternative:

  • Azithromycin 1 g orally as a single dose 2, 4

Syphilis (Early, <1 year duration)

Benzathine penicillin G 2.4 million units IM as a single dose is first-line 2.

For penicillin allergy:

  • Doxycycline 100 mg orally twice daily for 2 weeks 2, 3

Syphilis (Late, >1 year duration)

Benzathine penicillin G 2.4 million units IM weekly for 3 weeks 2.

For penicillin allergy:

  • Doxycycline 100 mg orally twice daily for 4 weeks 2, 3

Chancroid (Genital Ulcer Disease)

Azithromycin 1 g orally as a single dose 4.

Alternatives:

  • Ceftriaxone 250 mg IM as a single dose 2
  • Ciprofloxacin 500 mg orally twice daily for 3 days 2

Urinary Tract Infections

Uncomplicated Cystitis (Lower UTI)

First-line agents:

  • Nitrofurantoin 100 mg twice daily for 5 days 5
  • TMP-SMX 1 double-strength tablet twice daily for 3 days 6, 5

Alternatives (if resistance patterns permit):

  • Fosfomycin 3 g as a single dose 5
  • Amoxicillin-clavulanate 875/125 mg twice daily for 5-7 days 5

Avoid fluoroquinolones as first-line due to increasing resistance and adverse effects 7, 5.

Complicated Urinary Tract Infections (cUTI)

Fluoroquinolones should not be used as first-line for serious cUTIs when risk factors for resistant organisms exist 5.

Mild-to-moderate cUTI (oral therapy):

  • TMP-SMX 1 double-strength tablet twice daily for 7-14 days 6, 5
  • Ciprofloxacin 500 mg twice daily for 7-14 days (if local resistance <10%) 5
  • Levofloxacin 750 mg daily for 5-7 days (if local resistance <10%) 5

Severe cUTI or risk factors for resistant organisms (IV therapy):

  • Piperacillin-tazobactam 3.375 g IV every 6 hours 5
  • Carbapenems (ertapenem 1 g IV daily, meropenem 1 g IV every 8 hours) 5
  • Ceftriaxone 1-2 g IV daily (if susceptibility confirmed) 5

Duration: 7-14 days for cUTI; up to 4 weeks for complicated pyelonephritis with abscess 5.

Acute Pyelonephritis (Uncomplicated)

Outpatient oral therapy:

  • Ciprofloxacin 500 mg twice daily for 7 days 5
  • Levofloxacin 750 mg daily for 5 days 5
  • TMP-SMX 1 double-strength tablet twice daily for 14 days (if local resistance <20%) 6, 5

Hospitalized patients:

  • Ceftriaxone 1-2 g IV daily 5
  • Ciprofloxacin 400 mg IV every 12 hours 5
  • Piperacillin-tazobactam 3.375 g IV every 6 hours (if severe or septic) 5

Transition to oral therapy once clinically stable, typically after 24-48 hours 5.

Acute Bacterial Prostatitis

Empiric therapy (pending cultures):

  • Ciprofloxacin 500 mg orally twice daily for 4-6 weeks 8
  • Levofloxacin 500 mg orally daily for 4-6 weeks 8
  • TMP-SMX 1 double-strength tablet twice daily for 4-6 weeks 8, 6

Severe/hospitalized patients:

  • Piperacillin-tazobactam 4.5 g IV every 6-8 hours 8
  • Ceftriaxone 1-2 g IV daily PLUS gentamicin 5 mg/kg daily 8

Critical caveat: Do NOT perform prostatic massage in acute bacterial prostatitis—risk of bacteremia and sepsis 8.


Key Principles Across All Infections

Antibiotic Stewardship

  • Avoid fluoroquinolones as first-line for mild infections where other options exist due to serious adverse effects and resistance 7, 5
  • Reserve carbapenems, linezolid, and daptomycin for life-threatening situations or confirmed resistant organisms 9
  • Use shortest effective duration: 5 days for uncomplicated cellulitis, 3 days for uncomplicated cystitis 1, 5

Common Pitfalls

  • Do not add MRSA coverage reflexively to cellulitis without specific risk factors 1
  • Do not use doxycycline or TMP-SMX as monotherapy for cellulitis—inadequate streptococcal coverage 1
  • Do not continue ineffective antibiotics beyond 48 hours—reassess for complications or resistant organisms 1
  • Do not prescribe antibiotics for simple abscesses without surrounding cellulitis—drainage is primary treatment 2, 1

Related Questions

What is the appropriate treatment for a patient with a urinary tract infection indicated by urinalysis results?
Should a patient with hematuria, leukocytes in UA, and mild fever be treated with antibiotics for a suspected UTI?
What is the best treatment approach for an 83-year-old female with recurrent, antibiotic-resistant Urinary Tract Infections (UTIs)?
What is the management plan for an 88-year-old male with a complicated Urinary Tract Infection (UTI) and a suprapubic catheter, who has a urine culture growing Enterococcus with greater than 100,000 colonies and Pseudomonas with less than 100,000 colonies, and has Impaired Renal Function with a Glomerular Filtration Rate (GFR) of 12, despite being asymptomatic?
Can a 28-year-old female with a history of urinary tract infection (UTI), bacterial vaginosis (BV), and candidiasis, who was previously treated with Macrobid (nitrofurantoin) and Fluconazole, be retreated with Macrobid for a new onset UTI, or should she be switched to Bactrim (trimethoprim-sulfamethoxazole)?
Why are preterm babies prone to sepsis?
What is the life expectancy of a patient with stage 4 follicular non-Hodgkin's lymphoma (NHL)?
What is the management for a patient with polyuria and polydipsia, who has undergone a water deprivation test showing increased urine osmolarity, indicating central diabetes insipidus?
What is the safest pharmacotherapy option for a patient with insomnia, considering potential substance abuse or dependence history?
What is the safest approach for withdrawing a postmenopausal woman with a history of breast cancer from anastrazole (Arimidex), considering potential side effects like osteoporosis?
What are the risk factors from the mother and a preterm (less than 37 weeks gestation) baby that predispose the baby to sepsis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.